Investors flock to Chinese herbal medicine stock with no revenues
June 17 (UPI) -- Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split...
investors
China’s investors, sick of ailing returns, see traditional Chinese medicine as a cure
The Kangmei TCM material price index, a barometer of the country’s medicinal herb market since receiving government approval in 2012,...
